CompaniesIGF Oncology

IGF Oncology

defunct

About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

94

By Phase

PHASE1/PHASE2: 1PHASE1: 1

By Status

TERMINATED: 1COMPLETED: 1

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

Today

Hover over trial bars to see details

Recent Trials

NCT03175978Lead Sponsor

IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome

PHASE1/PHASE2Terminated

Started: Feb 21, 2018 · Completed: Sep 30, 2021

NCT02045368Lead Sponsor

Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R

PHASE1Completed

92 participants

Started: Jan 28, 2014 · Completed: Sep 30, 2016

Funding History (1)

D

Jul 10, 2018